Publications
List of scientific publications involving Neuro-SysMed researchers, in chronological order as they appear in PubMed.
Scientific publications involving Neuro-SysMed's researchers and fields
|
Molecular landscape of the overlap between Alzheimer's disease and somatic insulin-related diseases. Ruisch IH, Widomska J, De Witte W, Mota NR, Fanelli G, Van Gils V, Jansen WJ, Vos SJB, Fóthi A, Barta C, Berkel S, Alam KA, Martinez A, Haavik J, O'Leary A, Slattery D, Sullivan M, Glennon J, Buitelaar JK, Bralten J, Franke B, Poelmans G. Alzheimers Res Ther. 2024 Oct 28;16(1):239. doi: 10.1186/s13195-024-01609-2. PMID: 39465382 Free PMC article. |
|
Hillert J, Butzkueven H, Magyari M, Wergeland S, Moore N, Soilu-Hänninen M, Ziemssen T, Kuhle J, Pontieri L, Forsberg L, Aarseth JH, Zhu C, Sicignano N, Mushnikov V, Bezemer I, Sabidó M. Clin Epidemiol. 2024 Oct 17;16:717-732. doi: 10.2147/CLEP.S480525. eCollection 2024. PMID: 39435029 Free PMC article. |
|
The Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis. Kråkenes T, Sandvik CE, Ytterdal M, Gavasso S, Evjenth EC, Bø L, Kvistad CE. Int J Mol Sci. 2024 Sep 24;25(19):10292. doi: 10.3390/ijms251910292. PMID: 39408622 Free PMC article. Review. |
|
The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis. Coerver E, Schoof L, Hogenboom L, Wessels M, van Ruyven P, van Samkar A, Mostert J, van Kempen Z, van Oosten BW, Wokke BH, Tallantyre E, Myhr KM, Torkildsen O, Killestein J, Smets I, Strijbis E. Mult Scler Relat Disord. 2024 Sep 28;91:105900. doi: 10.1016/j.msard.2024.105900. Online ahead of print. PMID: 39369631 |
|
Olsen CG, Malmberg VN, Fahlström M, Alstadhaug KB, Bjørnå IK, Braathen GJ, Bråthen G, Demic N, Hallerstig E, Hogenesch I, Horn MA, Kampman MT, Kleveland G, Ljøstad U, Maniaol A, Morsund ÅH, Nakken O, Schlüter K, Schuler S, Seim E, Flemmen HØ, Tysnes OB, Holmøy T, Høyer H. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Sep 24:1-9. doi: 10.1080/21678421.2024.2405118. Online ahead of print. PMID: 39316038 |
|
Dick F, Johanson GAS, Tysnes OB, Alves G, Dölle C, Tzoulis C. Mol Neurobiol. 2024 Aug 21. doi: 10.1007/s12035-024-04422-y. Online ahead of print. PMID: 39164482 |
|
Pedersen CC, Ushakova A, Alves G, Tysnes OB, Blennow K, Zetterberg H, Maple-Grødem J, Lange J. NPJ Parkinsons Dis. 2024 Aug 21;10(1):162. doi: 10.1038/s41531-024-00768-1. PMID: 39164268 Free PMC article. |
|
Orthostatic Hypotension and Risk of Mild Cognitive Impairment and Dementia in Parkinson's Disease. Hiorth YH, Schulz J, Pedersen KF, Tysnes OB, Alves G. Mov Disord Clin Pract. 2024 Aug 6. doi: 10.1002/mdc3.14179. Online ahead of print. PMID: 39108067 |
|
Torgauten HM, Onyango TB, Ljostveit S, Hallin EI, Serkland TT, Skrede S, Langeland N, Cox RJ, Wergeland S, Myhr KM, Torkildsen Ø. Mult Scler Relat Disord. 2024 Sep;89:105770. doi: 10.1016/j.msard.2024.105770. Epub 2024 Jul 15. PMID: 39029342 |
|
Activation of Neurotoxic Astrocytes Due to Mitochondrial Dysfunction Triggered by POLG Mutation. Liang KX, Chen A, Kianian A, Kristiansen CK, Yangzom T, Furriol J, Høyland LE, Ziegler M, Kråkenes T, Tzoulis C, Fang EF, Sullivan GJ, Bindoff LA. Int J Biol Sci. 2024 May 11;20(8):2860-2880. doi: 10.7150/ijbs.93445. eCollection 2024. PMID: 38904024 Free PMC article. |
|
Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms. Tai MDS, Gamiz-Arco G, Martinez A. Biochem Soc Trans. 2024 Jun 26;52(3):1275-1291. doi: 10.1042/BST20231061. PMID: 38813865 Free PMC article. Review. |
|
Kvistad CE, Kråkenes T, Gavasso S, Bø L. Front Neurol. 2024 May 9;15:1398089. doi: 10.3389/fneur.2024.1398089. eCollection 2024. PMID: 38803647 Free PMC article. Review. |
|
Førsund E, Torrado Vidal JC, Fæø SE, Reithe H, Patrascu M, Husebo BS. Front Public Health. 2024 Apr 30;12:1380922. doi: 10.3389/fpubh.2024.1380922. eCollection 2024. PMID: 38745999 Free PMC article. |
|
Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease. Flønes IH, Toker L, Sandnes DA, Castelli M, Mostafavi S, Lura N, Shadad O, Fernandez-Vizarra E, Painous C, Pérez-Soriano A, Compta Y, Molina-Porcel L, Alves G, Tysnes OB, Dölle C, Nido GS, Tzoulis C. Nat Commun. 2024 Apr 29;15(1):3631. doi: 10.1038/s41467-024-47867-4. PMID: 38684731 Free PMC article. |
|
The STRAT-PARK cohort: A personalized initiative to stratify Parkinson's disease. Stige KE, Kverneng SU, Sharma S, Skeie GO, Sheard E, Søgnen M, Geijerstam SA, Vetås T, Wahlvåg AG, Berven H, Buch S, Reese D, Babiker D, Mahdi Y, Wade T, Miranda GP, Ganguly J, Tamilselvam YK, Chai JR, Bansal S, Aur D, Soltani S, Adams S, Dölle C, Dick F, Berntsen EM, Grüner R, Brekke N, Riemer F, Goa PE, Haugarvoll K, Haacke EM, Jog M, Tzoulis C. Prog Neurobiol. 2024 May;236:102603. doi: 10.1016/j.pneurobio.2024.102603. Epub 2024 Apr 10. PMID: 38604582 |
|
Novy C, Busk ØL, Tysnes OB, Landa SS, Aanjesen TN, Alstadhaug KB, Bjerknes TL, Bjørnå IK, Bråthen G, Dahl E, Demic N, Fahlström M, Flemmen HØ, Hallerstig E, HogenEsch I, Kampman MT, Kleveland G, Kvernmo HB, Ljøstad U, Maniaol A, Morsund AH, Nakken O, Olsen CG, Schlüter K, Utvik MS, Yaseen R, Holla ØL, Holmøy T, Høyer H. Brain Commun. 2024 Mar 14;6(2):fcae087. doi: 10.1093/braincomms/fcae087. eCollection 2024. PMID: 38585669 Free PMC article. |
|
Vislapuu M, Patrascu M, Allore H, Husebo BS, Kjerstad E, Gedde MH, Berge LI. Innov Aging. 2024 Feb 23;8(3):igae020. doi: 10.1093/geroni/igae020. eCollection 2024. PMID: 38550899 Free PMC article. |
|
Kalincik T, Sharmin S, Roos I, Massey J, Sutton I, Withers B, Freedman MS, Atkins H, Krasulova E, Kubala Havrdova E, Trneny M, Kozak T, Burman J, Macdonell R, Torkildsen Ø, Bø L, Lehmann AK, Sharrack B, Snowden J. J Neurol Neurosurg Psychiatry. 2024 Jul 15;95(8):775-783. doi: 10.1136/jnnp-2023-332790. PMID: 38538060 |
|
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis. Lereim RR, Nytrova P, Guldbrandsen A, Havrdova EK, Myhr KM, Barsnes H, Berven FS. PLoS One. 2024 Mar 25;19(3):e0300914. doi: 10.1371/journal.pone.0300914. eCollection 2024. PMID: 38527011 Free PMC article. |
|
van Dam PH, Achterberg WP, Husebo BS, Caljouw MA. BMC Geriatr. 2024 Mar 22;24(1):279. doi: 10.1186/s12877-024-04795-8. PMID: 38519888 Free PMC article. Clinical Trial. |
|
Van Damme P, Al-Chalabi A, Andersen PM, Chiò A, Couratier P, De Carvalho M, Hardiman O, Kuźma-Kozakiewicz M, Ludolph A, McDermott CJ, Mora JS, Petri S, Probyn K, Reviers E, Salachas F, Silani V, Tysnes OB, van den Berg LH, Villanueva G, Weber M. Eur J Neurol. 2024 Jun;31(6):e16264. doi: 10.1111/ene.16264. Epub 2024 Mar 12. PMID: 38470068 Free PMC article. |
|
BCG vaccination and multiple sclerosis risk: A Norwegian cohort study. Nakken O, Aarseth JH, Wergeland S, Stigum H, Meyer HE, Holmøy T. Mult Scler. 2024 May;30(6):646-653. doi: 10.1177/13524585241230440. Epub 2024 Feb 27. PMID: 38414125 Free PMC article. |
|
Gottschlich KN, Zolic-Karlsson Z, Aas E, Kvistad SAS, Bø L, Torkildsen Ø, Lehmann AK. Mult Scler Relat Disord. 2024 Apr;84:105507. doi: 10.1016/j.msard.2024.105507. Epub 2024 Feb 16. PMID: 38412758 |
|
Impact of Pain and Neuropsychiatric Symptoms on Activities in Nursing Home Residents (COSMOS Trial). van de Beek SH, Erdal A, Husebø BS, Vislapuu M, Achterberg WP, Caljouw MAA. J Am Med Dir Assoc. 2024 May;25(5):847-852.e3. doi: 10.1016/j.jamda.2024.01.012. Epub 2024 Feb 22. PMID: 38403273 Clinical Trial. |
|
Collins JT, Walsh DA, Gladman JRF, Patrascu M, Husebo BS, Adam E, Cowley A, Gordon AL, Ogliari G, Smaling H, Achterberg W. Drugs Aging. 2024 Mar;41(3):199-208. doi: 10.1007/s40266-024-01101-4. Epub 2024 Feb 24. PMID: 38401025 Free PMC article. |
|
Hong Y, Zhang Z, Yangzom T, Chen A, Lundberg BC, Fang EF, Siller R, Sullivan GJ, Zeman J, Tzoulis C, Bindoff LA, Liang KX. Int J Biol Sci. 2024 Jan 25;20(4):1194-1217. doi: 10.7150/ijbs.91624. eCollection 2024. PMID: 38385069 Free PMC article. |
|
Kvistad CE, Lehmann AK, Kvistad SAS, Holmøy T, Lorentzen ÅR, Trovik LH, Kristoffersen EK, Bø L, Torkildsen Ø. Mult Scler. 2024 May;30(6):751-754. doi: 10.1177/13524585241231665. Epub 2024 Feb 12. PMID: 38345003 Free PMC article. |
|
Titlestad I, Haugarvoll K, Solvang SH, Norekvål TM, Skogseth RE, Andreassen OA, Årsland D, Neerland BE, Nordrehaug JE, Tell GS, Giil LM. Age Ageing. 2024 Feb 1;53(2):afae006. doi: 10.1093/ageing/afae006. PMID: 38342753 Free PMC article. |
|
Eid K, Bjørk MH, Gilhus NE, Torkildsen Ø. Int J Mol Sci. 2024 Jan 26;25(3):1520. doi: 10.3390/ijms25031520. PMID: 38338799 Free PMC article. Review. |
|
Gavasso S, Kråkenes T, Olsen H, Evjenth EC, Ytterdal M, Haugsøen JB, Kvistad CE. Int J Mol Sci. 2024 Jan 23;25(3):1365. doi: 10.3390/ijms25031365. PMID: 38338644 Free PMC article. Review. |
|
Taule T, Tysnes OB, Aßmus J, Rekand T. Ann Palliat Med. 2024 Jan;13(1):86-92. doi: 10.21037/apm-23-386. PMID: 38316400 |
|
Oral symptoms in dying nursing home patients. Results from the prospective REDIC study. Sandvik RKNM, Husebo BS, Selbaek G, Strand G, Patrascu M, Mustafa M, Bergh S. BMC Oral Health. 2024 Jan 25;24(1):129. doi: 10.1186/s12903-024-03901-x. PMID: 38273300 Free PMC article. |
|
Fatigue in Parkinson's Disease: A Proteomic Study of Cerebrospinal Fluid. Eidem LE, Birkeland E, Austdal M, Bårdsen K, Lange J, Alves G, Berven F, Nilsen MM, Herlofson K, Tysnes OB, Omdal R. Mov Disord. 2024 Apr;39(4):749-751. doi: 10.1002/mds.29715. Epub 2024 Jan 20. PMID: 38243743 No abstract available. |
|
Antiviral therapy with tenofovir in MS. Torkildsen Ø, Myhr KM, Brugger-Synnes P, Bjørnevik K. Mult Scler Relat Disord. 2024 Mar;83:105436. doi: 10.1016/j.msard.2024.105436. Epub 2024 Jan 7. PMID: 38217968 |
|
Health phenome of Parkinson's patients reveals prominent mood-sleep cluster. Olsen A, Locascio J, Tuncali I, Laroussi N, Abatzis E, Kamenskaya P, Kuras Y, Yi T, Videnovic A, Hayes M, Ho G, Paulson J, Khurana V, Herrington T, Hyman B, Selkoe D, Growdon J, Gomperts S, Riise T, Schwarzschild M, Hung A, Wills A, Scherzer C. Res Sq [Preprint]. 2023 Dec 22:rs.3.rs-3683455. doi: 10.21203/rs.3.rs-3683455/v1. PMID: 38196602 Free PMC article. Preprint. |
|
Jung-Kc K, Tristán-Noguero A, Altankhuyag A, Piñol Belenguer D, Prestegård KS, Fernandez-Carasa I, Colini Baldeschi A, Sigatulina Bondarenko M, García-Cazorla A, Consiglio A, Martinez A. J Inherit Metab Dis. 2024 May;47(3):494-508. doi: 10.1002/jimd.12702. Epub 2024 Jan 9. PMID: 38196161 |
|
Mouse models for inherited monoamine neurotransmitter disorders. Thöny B, Ng J, Kurian MA, Mills P, Martinez A. J Inherit Metab Dis. 2024 May;47(3):533-550. doi: 10.1002/jimd.12710. Epub 2024 Jan 2. PMID: 38168036 Review. |
|
Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders. Olsen CG, Busk ØL, Holla ØL, Tveten K, Holmøy T, Tysnes OB, Høyer H. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Feb;25(1-2):177-187. doi: 10.1080/21678421.2023.2270705. Epub 2024 Jan 23. PMID: 37849306 |
|
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. Kalincik et al, incl. Torkildsen Ø, Bo L, Lehmann AK. JAMA Neurol. 2023 Jul 1;80(7):702-713. doi: 10.1001/jamaneurol.2023.1184. PMID: 3743740 |
|
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort. Sunderland KM et al, incl. Jog M. Alzheimers Dement. 2023 Jan;19(1):226-243. doi: 10.1002/alz.12632. Epub 2022 Mar 30. PMID: 36318754 |
|
Mitochondrial haplogroups and cognitive progression in Parkinson's disease. Liu G et al. incl. Tysnes OB. Brain. 2023 Jan 5;146(1):42-49. doi: 10.1093/brain/awac327. PMID: 36343661 Free PMC article. |
|
New centres to carry out more clinical trials in Norway. Skoie IM, Skogås JG, Langø T, Myhr KM, Myhre PL, Goll R, Fretland SØ, Helland Å. Tidsskr Nor Laegeforen. 2023 Jan 20;143(2). doi: 10.4045/tidsskr.22.0722. Print 2023 Jan 31. PMID: 36718905 English, Norwegian. No abstract available. |
|
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia. Gonzalez MC el al incl. Tysnes OB. Mov Disord Clin Pract. 2023 May 5;10(6):980-986. doi: 10.1002/mdc3.13752. |
|
Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative Disorders. Pedersen CC, Ushakova A, Skogseth RE, Alves G, Tysnes OB, Aarsland D, Lange J, Maple-Grødem J. Neurol Neuroimmunol Neuroinflamm. 2023 May 31;10(4):e200132. doi: 10.1212/ |
|
NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease. Berven H, Kverneng S, Sheard E, Søgnen M, Af Geijerstam SA, Haugarvoll K, Skeie GO, Dölle C, Tzoulis C. Nat Commun. 2023 Nov 28;14(1):7793. doi: 10.1038/s41467-023-43514-6. PMID: 38016950 Free PMC article. Clinical Trial. |
|
Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson's Disease. Oftedal L, Maple-Grødem J, Tysnes OB, Alves G, Lange J. J Parkinsons Dis. 2023;13(5):841-844. doi: 10.3233/JPD-230065. PMID: 37393438 Free PMC article. |
|
Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro. Førde JL, Herfindal L, Myhr KM, Torkildsen Ø, Mollnes TE, Skrede S. Int Immunopharmacol. 2023 Nov;124(Pt B):111021. doi:10.1016/j.intimp.2023.111021. Epub 2023 Oct 9. PMID: 37816262 |
|
Potassium channels in behavioral brain disorders. Molecular mechanisms and therapeutic potential: A narrative review. Alam KA, Svalastoga P, Martinez A, Glennon JC, Haavik J. Neurosci Biobehav Rev. 2023 Sep;152:105301. doi: 10.1016/j.neubiorev.2023.105301. Epub 2023 Jul 4. PMID: 37414376 Review. |
|
Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach. Maple-Grødem J, Ushakova A, Pedersen KF, Tysnes OB, Alves G, Lange J. Neurobiol Dis. 2023 Oct 1;186:106281. doi: 10.1016/j.nbd.2023.106281. Epub 2023 Sep 4. PMID: 37673381 |
|
Advancing nutrition science to meet evolving global health needs. Neufeld LM, Ho E, Obeid R, Tzoulis C, Green M, Huber LG, Stout M, Griffiths JC. Eur J Nutr. 2023 Dec;62(Suppl 1):1-16. doi: 10.1007/s00394-023-03276-9. Epub 2023 Nov 28. PMID: 38015211 Free PMC article. |
|
Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson's disease. Dick F, Tysnes OB, Alves GW, Nido GS, Tzoulis C. iScience. 2023 Jan 4;26(2):105925. doi: 10.1016/j.isci.2023.105925. eCollection 2023 Feb 17. PMID: 36711240 Free PMC article. |
|
Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. Rød BE, Wergeland S, Bjørnevik K, Holmøy T, Ulvestad E, Njølstad G, Myhr KM, Torkildsen Ø. Mult Scler Relat Disord. 2023 Nov;79:105037. doi:10.1016/j.msard.2023.105037. Epub 2023 Sep 30. PMID: 37804765 Clinical Trial. |
|
Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease. Tuominen JA, Bjørnevik K, Romanowska J, Solheim MH, Grydeland TB, Cortese M, Scherzer CR, Riise T, Igland J. Parkinsonism Relat Disord. 2023 May;110:105389. doi: 10.1016/j.parkreldis.2023.105389. Epub 2023 Mar 31. PMID: 37027994 |
|
Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study. Roar M, Nielsen ARH, Berg JM, Sirakov G, Stilund M, Schäfer J, Ratzer R, Frederiksen J, Asgari N, Ashna SN, Jensen HB, Kant M, Theódorsdóttir Á, Illes Z, Sellebjerg F, Magyari M, Schlosser LM, Nordborg H, Wergeland S, Sejbaek Mult Scler Relat Disord. 2023 Dec;80:105127. doi:10.1016/j.msard.2023.105127. Epub 2023 Nov 5. PMID: 37956521 |
|
Predictors of hospitalization due to infection in rituximab-treated MS patients. Karlowicz JR, Klakegg M, Aarseth JH, Bø L, Myhr KM, Torgauten HM, Torkildsen Ø, Wergeland S. Mult Scler Relat Disord. 2023 Mar;71:104556. doi: 10.1016/j.msard.2023.104556. Epub 2023 Feb 11. PMID: 36842313 |
|
Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease. Gaare JJ, Dölle C, Brakedal B, Brügger K, Haugarvoll K, Nido GS, Tzoulis C. iScience. 2023 Feb 27;26(3):106278. doi: 10.1016/j.isci.2023.106278. eCollection 2023 Mar 17. PMID: 36936793 Free PMC article. |
|
Treatment of motor symptoms in Parkinson's disease. Dietrichs E, Alves G, Benjaminsen E, Johansen KK, Tysnes OB. Tidsskr Nor Laegeforen. 2023 May 4;143(7). doi: 10.4045/tidsskr.22.0804. Print 2023 May 9. PMID: 37158528 English, Norwegian. |
|
Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function. Kapustin D et al, incl. Jog M. Can J Psychiatry. 2023 May;68(5):347-358. doi:10.1177/07067437221147443. Epub 2023 Jan 13. PMID: 36637224 Free PMC article. |
|
Classification and staging of Parkinson's disease using video-based eye tracking. Brien DC, Riek HC, Yep R, Huang J, Coe B, Areshenkoff C, Grimes D, Jog M, Lang A, Marras C, Masellis M, McLaughlin P, Peltsch A, Roberts A, Tan B, Beaton D, Lou W, Swartz R; ONDRI Investigators; Munoz DP. Parkinsonism Relat Disord. 2023 May;110:105316. doi: 10.1016/j.parkreldis.2023.105316. Epub 2023 Feb 8. PMID: 36822878 |
|
Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis. Riemer F, Skorve E, Pasternak O, Zaccagna F, Lundervold AJ, Torkildsen Ø, Myhr KM, Grüner R. Commun Med (Lond). 2023 Jun 22;3(1):90. doi:10.1038/s43856-023-00319-4. PMID: 37349545 Free PMC article. |
|
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases. Ozzoude M et al, incl. Jog M. Alzheimers Res Ther. 2023 Jun 20;15(1):114. doi: 10.1186/s13195-023-01257-y. PMID: 37340319 Free PMC article. |
|
Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study. Kapali A, Daltveit AK, Myhr KM, Bjornevik K, Baldin E, Pugliatti M, Riise T, Cortese M. J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):8-13. doi:10.1136/jnnp-2023-331241. PMID: 37479464 |
|
An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis. Ahmad I, Wergeland S, Oveland E, Bø L. ASN Neuro. 2023 Jan-Dec;15:17590914231198980. doi:10.1177/17590914231198980. PMID: 38062768 Free PMC article. |
|
Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS - A longitudinal correlation study. Skorve E, Lundervold AJ, Torkildsen Ø, Riemer F, Grüner R, Myhr KM. Mult Scler Relat Disord. 2023 Jan;69:104398. doi: 10.1016/j.msard.2022.104398. |
|
The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial. Chwiszczuk LJ, Breitve MH, Kirsebom BB, Selnes P, Fløvig JC, Knapskog AB, Front Aging Neurosci. 2023 May 26;15:1163184. doi:10.3389/fnagi.2023.1163184. eCollection 2023. PMID: 37304077 Free PMC article. |
|
Cancer related mortality in multiple sclerosis. A population based cohort study. Grytten N, Myhr KM, Celius EG, Benjaminsen E, Midgard R, Vatne A, Aarseth JH, Mannseth J, Torkildsen Ø. Mult Scler Relat Disord. 2023 Jan;69:104417. doi: 10.1016/j.msard.2022.104417. Epub 2022 Nov 17. PMID: 36423459 |
|
Physical Activity in Multiple Sclerosis: Meeting the Guidelines at the Time of the COVID-19 Pandemic. Pedullà L, Santoyo-Medina C, Novotna K, Moumdjian L, Smedal T, Arntzen EC, van der Linden ML, Learmonth Y, Kalron A, Güngör F, Nedeljkovic U, Kos D, Jonsdottir J, Coote S, Tacchino A. J Neurol Phys Ther. 2023 Apr 1;47(2):112-121. doi: 10.1097/NPT.0000000000000430. Epub 2023 Jan 31. PMID: 36753458 |
|
Editorial: New cerebrospinal fluid research to uncover mechanisms driving neurological and psychiatric diseases, volume II. Skripuletz T, Torkildsen Ø. Front Neurol. 2023 Dec 12;14:1346377. doi: 10.3389/fneur.2023.1346377. eCollection 2023. PMID: 38148983 Free PMC article. No abstract available. |
|
Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis. Lie IA, Rød BE, Kvistad SS, Holmøy T, Myhr KM, Torkildsen Ø, Wergeland S. Mult Scler Relat Disord. 2023 Feb;70:104530. doi: 10.1016/j.msard.2023.104530. |
|
Robot-assisted investigation of sensorimotor control in Parkinson's disease. Tamilselvam YK, Jog M, Patel RV. Sci Rep. 2023 Mar 23;13(1):4751. doi: 10.1038/s41598-023-31299-z. PMID: 36959273 Free PMC article. |
|
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative. Carvalho de Abreu DC et al, incl. Jog M. Eur J Neurol. 2023 Apr;30(4):920-933. doi: 10.1111/ene.15692. Epub 2023 Feb 14. |
|
Access to, use of, and experiences with social alarms in home-living people with dementia: results from the LIVE@Home.Path trial. Puaschitz NGS, Jacobsen FF, Berge LI, Husebo BS. Front Aging Neurosci. 2023 May 22;15:1167616. doi: 10.3389/fnagi.2023.1167616. eCollection 2023. PMID: 37284020 Free PMC article. |
|
Application of Flow Cytometric Analysis for Measuring Multiple Mitochondrial Parameters in 3D Brain Organoids. Marjan S, Yangzom T, Kristiansen CK, Chen A, Bindoff LA, Liang KX. J Vis Exp. 2023 Aug 4;(198). doi: 10.3791/65621. PMID: 37590511 |
|
The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination. Kråkenes T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, Fromreide S, Costea DE, Mustafa K, Bø L, Kvistad CE. PLoS One. 2023 Nov 9;18(11):e0293908. doi: 10.1371/journal.pone.0293908. eCollection 2023. PMID: 37943848 Free PMC article. Clinical Trial. |
|
Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability. Taule T, Eide IS, Fjær L, Myrberget MA, Oseland MS, Renså MA, Revheim T, Tysnes OB, Aßmus J, Rekand T. PLoS One. 2023 May 4;18(5):e0285307. doi: 10.1371/journal.pone.0285307. eCollection 2023. PMID: 37141321 Free PMC article. |
|
Pain and quality of life in nursing home residents with dementia after admission - a longitudinal study. Helvik AS, Bergh S, Šaltytė Benth J, Borza T, Husebø B, Tevik K. BMC Health Serv Res. 2023 Sep 27;23(1):1032. doi: 10.1186/s12913-023- |
|
Cognitive Profile in Parkinson's Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta. Tufekcioglu Z, Lange J, Pedersen KF, Tysnes OB, Alves G, Emre M. Dement Geriatr Cogn Dis Extra. 2023 Oct 26;13(1):39-47. doi:10.1159/000534552. eCollection 2023 Jan-Dec. PMID: 38025590 Free PMC article. |
|
Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease. Oftedal L, Maple-Grødem J, Dalen I, Tysnes OB, Pedersen KF, Alves G, Lange Neurology. 2023 Jan 24;100(4):e388-e395. doi:10.1212/WNL.0000000000201418. Epub 2022 Oct 17. PMID: 36253102 Free PMC article. |
|
Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study. Habbestad A, Willumsen JS, Aarseth JH, Grytten N, Midgard R, Wergeland S, Myhr KM, Torkildsen Ø. J Neurol. 2023 Dec 14. doi: 10.1007/s00415-023-12047-9. Online ahead of print.PMID: 38097800 |
|
Early GCase activity is a predictor of long-term cognitive decline in Parkinson's disease. Oftedal L, Lange J, Pedersen KF, Erga AH, Dalen I, Tysnes OB, Alves G, Maple-Grødem J. Transl Neurodegener. 2023 Aug 28;12(1):41. doi: 10.1186/s40035-023-00373-x. PMID: 37635244 Free PMC article. No abstract available. |
|
Robotics-Based Characterization of Sensorimotor Integration in Parkinson's Disease and the Effect of Medication. Tamilselvam YK, Jog MS, Patel RV. IEEE Trans Neural Syst Rehabil Eng. 2023;31:3201-3211. doi:10.1109/TNSRE.2023.3299884. Epub 2023 Aug 9. PMID: 37506007 |
|
A Comparison of Voice Amplifiers and Personal Communication Systems for Hypophonia: An Exploration of Communicative Participation. Page AD, Schroeder JR, Knowles T, Jog M, Adams SG. Am J Speech Lang Pathol. 2023 Aug 17;32(4S):1850-1865. doi:10.1044/2023_AJSLP-22-00161. Epub 2023 Mar 23. PMID: 36958017 Clinical Trial. |
|
Not every estimate counts - evaluation of cell composition estimation approaches in brain bulk tissue data. Toker L, Nido GS, Tzoulis C. Genome Med. 2023 Jun 7;15(1):41. doi: 10.1186/s13073-023-01195-2. PMID: 37287013 Free PMC article. |
|
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis. Butzkueven H, Hillert J, Soilu-Hänninen M, Ziemssen T, Kuhle J, Wergeland S, Magyari M, Berger JR, Moore N, Aydemir A, Bezemer I, Sabidó M. Curr Med Res Opin. 2023 Oct;39(10):1367-1374. doi:10.1080/03007995.2023.2256220. Epub 2023 Sep 7. PMID: 37675878 |
|
Changes in physical activity participation during the COVID-19 pandemic in people with multiple sclerosis: An international survey study. van der Linden ML, Kos D, Moumdjian L, Kalron A, Coote S, Smedal T, Arntzen EC, Tayfur SN, Pedullà L, Tacchino A, Jonsdottir J, Santoyo-Medina C, Novotna K, Yazgan YZ, Nedeljkovic U, Learmonth YC. Ann Phys Rehabil Med. 2023 Oct;66(7):101798. doi: 10.1016/j.rehab.2023.101798. Epub 2023 Nov 14. PMID: 37967488 No abstract available |
|
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations. König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO. J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):19-22. doi: 10.1136/jnnp-2021-327612. Epub 2021 Oct 20. PMID: 34670844 Free PMC article. |
|
DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease. Gaare JJ, Brügger K, Nido GS, Tzoulis C. Mov Disord. 2023 Nov;38(11):2064-2071. doi: 10.1002/mds.29574. Epub 2023 Aug 7. PMID: 37551021 |
|
Visual velocity perception dysfunction in Parkinson's disease. Bernardinis M, Atashzar SF, Jog MS, Patel RV. Behav Brain Res. 2023 Aug 24;452:114490. doi:10.1016/j.bbr.2023.114490. Epub 2023 May 10. PMID: 37172741 |
|
Changes in physiotherapy services and use of technology for people with multiple sclerosis during the COVID-19 pandemic. Jonsdottir J, Santoyo-Medina C, Kahraman T, Kalron A, Rasova K, Moumdjian L, Coote S, Tacchino A, Grange E, Smedal T, Arntzen EC, Learmonth Y, Pedulla L, Quinn G, Kos D. Mult Scler Relat Disord. 2023 Mar;71:104520. doi: 10.1016/j.msard.2023.104520. |
|
Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study. Romanowska J, Bjornevik K, Cortese M, Tuominen JA, Solheim M, Abolpour Mofrad A, Igland J, Scherzer CR, Riise T. Neurology. 2023 Nov 21;101(21):e2068-e2077. doi:10.1212/WNL.0000000000207899. Epub 2023 Oct 10. PMID: 37816645 Free PMC article. |
|
Neuronal loss drives differentially expressed protein-pathways in the PSP globus pallidus. Dick F, Johanson GS, Tzoulis C. Clin Transl Med. 2023 Jul;13(7):e1280. doi: 10.1002/ctm2.1280. PMID: |
|
Neurofilament and Brain Atrophy and Their Association with Cognition in Multiple Sclerosis: A 10-Year Follow-Up Study. Bhan A, Jacobsen, C, Dalen I, Alves G, Bergsland N, Myhr KM, Zetterberg Acta Neurol Scand 2023 DEC 23: DOI10.1155/2023/7136599 |
- Jensen SM, Müller KI, Mellgren SI, Bindoff LA, Rasmussen M, Ørstavik K, Jonsrud C, Tveten K, Nilssen Ø, Van Ghelue M, Arntzen KA.
Epidemiology and natural history in 101 subjects with FKRP-related limb-girdle muscular dystrophy R9. The Norwegian LGMDR9 cohort study (2020).
Neuromuscul Disord. 2023 Feb;33(2):119-132. doi:10.1016/j.nmd.2022.11.005. Epub 2022 Nov 25. PMID: 36522254. - Oftedal L, Maple-Grødem J, Dalen I, Tysnes OB, Pedersen KF, Alves G, Lange J.
Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease.
Neurology. 2023 Jan 24;100(4):e388-e395. doi: 10.1212/WNL.0000000000201418. Epub 2022 Oct 17. PMID: 36253102. - Skorve E, Lundervold AJ, Torkildsen Ø, Riemer F, Grüner R, Myhr KM.
Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS - A longitudinal correlation study.
Mult Scler Relat Disord. 2023 Jan;69:104398. doi: 10.1016/j.msard.2022.104398. Epub 2022 Nov 5. PMID: 36462469. - Grytten N, Myhr KM, Celius EG, Benjaminsen E, Midgard R, Vatne A, Aarseth JH, Mannseth J, Torkildsen Ø.
Cancer related mortality in multiple sclerosis. A population based cohort study.
Mult Scler Relat Disord. 2023 Jan;69:104417. doi:10.1016/j.msard.2022.104417. Epub 2022 Nov 17. PMID: 36423459. - Sunderland KM et al. (incl. Jog M).
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort.
Alzheimers Dement. 2023 Jan;19(1):226-243. doi: 10.1002/alz.12632. Epub
2022 Mar 30. PMID: 36318754. - Lobbezoo F, Verhoeff MC, Aarab G, Husebø BS, van der Torre W, Volgenant CMC.
The contribution of palliative oral health care to dying with dignity.
J Am Dent Assoc. 2023 Jan;154(1):3-5. doi: 10.1016/j.adaj.2022.08.015. Epub 2022 Oct 15. PMID:36253165. - Helvik AS, Bergh S, Kabukcuoğlu K, Šaltytė Benth J, Lichtwarck B, Husebø B, Tevik K.
Prevalence and persistent prescription of analgesic drugs in persons admitted with dementia to a nursing home - A longitudinal study.
PLoS One. 2022 Dec 30;17(12):e0279909. doi: 10.1371/journal.pone.0279909. eCollection 2022. PMID: 36584218. - Boyle LD, Husebo BS, Vislapuu M.
Promotors and barriers to the implementation and adoption of assistive technology and telecare for people with dementia and their caregivers: a systematic review of the literature.
BMC Health Serv Res. 2022 Dec 23;22(1):1573. doi: 10.1186/s12913-022-08968-2. PMID: 36550456. - Bjerknes TL, Steihaug OM, Haugen M, Hjelland IE, Vedeler CA.
Case report: Pain in anti-DPPX encephalitis.
Front Neurol. 2022 Dec 14;13:1091688. doi: 10.3389/fneur.2022.1091688. eCollection 2022. PMID: 36588910. - Kropotov A, Kulikova V, Solovjeva L, Yakimov A, Nerinovski K, Svetlova M, Sudnitsyna J, Plusnina A, Antipova M, Khodorkovskiy M, Migaud ME, Gambaryan S, Ziegler M, Nikiforov A.
Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells.
J Biol Chem. 2022 Dec;298(12):102615. doi: 10.1016/j.jbc.2022.102615. Epub 2022 Oct 18. PMID: 36265580. - Lüscher B et al. (incl. Ziegler M).
ADPribosyltransferases, an update on function and nomenclature.
FEBS J. 2022 Dec;289(23):7399-7410. doi: 10.1111/febs.16142. Epub 2021 Sep 13. PMID: 34323016. - Støve SI, Skjevik ÅA, Teigen K, Martinez A.
Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone.
Commun Biol. 2022 Nov 23;5(1):1283. doi: 10.1038/s42003-022-04121-1. PMID: 36418492. - Vislapuu M, Berge LI, Angeles RC, Kjerstad E, Mannseth J, Achterberg WP, Husebo BS.
Factors associated with formal and informal resource utilization in nursing home patients with and without dementia: cross-sectional analyses from
the COSMOS trial.
BMC Health Serv Res. 2022 Nov 2;22(1):1306. doi: 10.1186/s12913-022-08675-y. PMID: 36324159. - Fernández-Vizarra E, López-Calcerrada S, Sierra-Magro A, Pérez-Pérez R, Formosa LE, Hock DH, Illescas M, Peñas A, Brischigliaro M, Ding S, Fearnley IM, Tzoulis C, Pitceathly RDS, Arenas J, Martín MA, Stroud DA, Zeviani M, Ryan MT, Ugalde C.
Two independent respiratory chains adapt OXPHOS performance to glycolytic switch.
Cell Metab. 2022 Nov 1;34(11):1792-1808.e6. doi:10.1016/j.cmet.2022.09.005. Epub 2022 Oct 4. PMID: 36198313. - Eid K, Torkildsen Ø, Aarseth J, Celius EG, Cortese M, Holmøy T, Kapali A, Myhr KM, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH.
Abuse and revictimization in adulthood in multiple sclerosis: a
cross-sectional study during pregnancy.
J Neurol. 2022 Nov;269(11):5901-5909. doi: 10.1007/s00415-022-11249-x. Epub 2022 Jul 3. PMID: 35780399. - Taule T, Morland AS, Aßmus J, Tysnes OB, Rekand T.
Translation, cultural adaptation, and validation of a screening test for cognitive and behavioural changes in amyotrophic lateral sclerosis.
Disabil Rehabil. 2022 Nov;44(23):7069-7077. doi:10.1080/09638288.2021.1980621. Epub 2021 Nov 2. PMID: 34726988. - Torkildsen Ø, Rød BE, Bø L, Wergeland S, Holmøy T, Myhr KM.
Breastfeeding and treatment for multiple sclerosis.
Tidsskr Nor Laegeforen. 2022 Oct 24;142(15). doi: 10.4045/tidsskr.22.0529. Print 2022 Oct 25. PMID: 36286559. - Torrado JC, Husebo BS, Allore HG, Erdal A, Fæø SE, Reithe H, Førsund E, Tzoulis C, Patrascu M.
Digital phenotyping by wearable-driven artificial intelligence in older adults and people with Parkinson’s disease: Protocol of the mixed method, cyclic ActiveAgeing study.
PLoS One. 2022 Oct 14;17(10):e0275747. doi: 10.1371/journal.pone.0275747. eCollection 2022. PMID: 36240173. - Nakken O, Holmøy T, Stigum H, Myhr KM, Dahl J, Heldal E, Meyer HE.
Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study.
Int J Epidemiol. 2022 Oct 13;51(5):1637-1644. doi:10.1093/ije/dyac039. PMID: 35278068. - Kristiansen CK, Chen A, Høyland LE, Ziegler M, Sullivan GJ, Bindoff LA, Liang KX.
Comparing the mitochondrial signatures in ESCs and iPSCs and their neural derivations.
Cell Cycle. 2022 Oct;21(20):2206-2221. doi:10.1080/15384101.2022.2092185. Epub 2022 Jul 10. PMID: 35815665. - Solvang SH, Hodge A, Watne LO, Cabral-Marques O, Nordrehaug JE, Giles GG, Dugué PA, Nygård O, Ueland PM, McCann A, Idland AV, Midttun Ø, Ulvik A, Halaas NB, Tell GS, Giil LM.
Kynurenine Pathway Metabolites in the Blood and Cerebrospinal Fluid Are Associated with Human Aging.
Oxid Med Cell Longev. 2022 Oct 21;2022:5019752. doi:10.1155/2022/5019752. eCollection 2022.PMID: 36312896. - Mayala S, Herdlevær I, Haugsøen JB, Anandan S, Blaser N, Gavasso S, Brun M.
GUBS: Graph-Based Unsupervised Brain Segmentation in MRI Images.
J Imaging. 2022 Sep 27;8(10):262. doi: 10.3390/jimaging8100262. PMID: 36286356 - Willumsen JS, Grytten N, Aarseth J, Myklebust TÅ, Myhr KM, Midgard R. Mortality and cause of death in multiple sclerosis in western Norway 1950-2021: a registry-based linkage study.
J Neurol Neurosurg Psychiatry. 2022 Sep 12;93(11):1154-61. doi:
10.1136/jnnp-2022-329169. Online ahead of print. PMID: 36096665. - Guitton R, Nido GS, Tzoulis C.
No evidence of extensive non-CpG methylation in mtDNA.
Nucleic Acids Res. 2022 Sep 9;50(16):9190-9194. doi:10.1093/nar/gkac701. PMID: 35979955. - Lie IA, Wesnes K, Kvistad SS, Brouwer I, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Barkhof F, Vrenken H, Myhr KM, Bø L, Torkildsen Ø.
The Effect of Smoking on Longterm Gray Matter Atrophy and Clinical Disability
in Patients with Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm. 2022 Jun 23;9(5):e200008. doi: 10.1212/NXI.0000000000200008. Print 2022 Sep. PMID:
35738901. - Helvik AS, Bergh S, Šaltytė Benth J, Selbaek G, Husebo BS, Tevik K.
Pain in nursing home residents with dementia and its association to quality of life.
Aging Ment Health. 2022 Sep;26(9):1787-1797. doi:10.1080/13607863.2021.1947968. Epub 2021 Jul 11. PMID: 34251936. - Berge LI, Gedde MH, Torrado Vidal JC, Husebo B, Hynninen KM, Knardal SE, Madsø KG.
The acceptability, adoption, and feasibility of a music application developed using participatory design for home-dwelling persons with dementia and their
caregivers. The “Alight” app in the LIVE@Home. Path trial.
Front Psychiatry. 2022 Aug 18;13:949393. doi: 10.3389/fpsyt.2022.949393. eCollection 2022. PMID: 36061298. - Samotus O, Mahdi Y, Jog M.
Real-World Longitudinal Experience of Botulinum Toxin Therapy for Parkinson and Essential Tremor.
Toxins (Basel). 2022 Aug 17;14(8):557. doi: 10.3390/toxins14080557. PMID:
36006219. - Ito E, Nouchi R, Dinet J, Cheng CH, Husebø BS.
The Effect of Music-Based Intervention on General Cognitive and Executive Functions, and Episodic Memory in People with Mild Cognitive Impairment
and Dementia: A Systematic Review and Meta-Analysis of Recent Randomized Controlled Trials.
Healthcare (Basel). 2022 Aug 3;10(8):1462. doi:10.3390/healthcare10081462. PMID: 36011119. - Tuesta Bernaola M, Ganguly J, Bansal S, Jog M.
Phenotypic Variability with Two Novel Variants in SPG15: Catching the Lynx by its Ears.
Mov Disord Clin Pract. 2022 Jun 1;9(6):832-836. doi: 10.1002/mdc3.13474. eCollection 2022 Aug. PMID:35937475. - Hallin EI, Trætteberg Serkland T, Myhr KM, Grytten Torkildsen Ø, Skrede S.
Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry.
J Mass Spectrom Adv Clin Lab. 2022 Jul 22;25:53-60. doi: 10.1016/j.jmsacl.2022.07.004. eCollection 2022 Aug. PMID: 35910410. - Dilliott AA et al. (incl. Jog M).
Targeted copy number variant identification across the neurodegenerative
disease spectrum.
Mol Genet Genomic Med. 2022 Aug;10(8):e1986. doi: 10.1002/mgg3.1986. Epub 2022 Jun 3. PMID: 35666053. - Kvistad SAS, Burman J, Lehmann AK, Tolf A, Zjukovskaja C, Melve GK, Bø L, Torkildsen Ø.
Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT.
J Neurol Neurosurg Psychiatry. 2022 Aug;93(8):844-848. doi: 10.1136/jnnp-2022-328797. Epub 2022 May 4. PMID: 35508373. - Guitton R, Dölle C, Alves G, Ole-Bjørn T, Nido GS, Tzoulis C.
Ultra-deep whole genome bisulfite sequencing reveals a single methylation
hotspot in human brain mitochondrial DNA.
Epigenetics. 2022 Aug;17(8):906-921. doi:10.1080/15592294.2022.2045754. Epub 2022 Mar 7. PMID: 35253628. - Rød BE, Torkildsen Ø, Myhr KM, Bø L, Wergeland S.
Safety of breast feeding during rituximab treatment in multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2022 Jul 25;94(1):38-41. doi: 10.1136/jnnp-2022-329545. Online ahead of print. PMID: 35879056. - Hestvik ALK, Frederiksen JL, Nielsen HH, Torkildsen Ø, Eek C, Huang-Link Y, Haghighi S, Tsai JA, Kant M.
Real-world study of relapsing-remitting multiple sclerosis patients treated with Teriflunomide in Nordic countries: Quality-Of-Life, efficacy, safety and
adherence outcomes.
Mult Scler Relat Disord. 2022 Jul;63:103892. doi: 10.1016/j.msard.2022.103892. Epub 2022 May 16. PMID: 35696880. - Ganguly J, Kulshreshtha D, Jog M.
Mercury and Movement Disorders: The Toxic Legacy Continues.
Can J Neurol Sci. 2022 Jul;49(4):493-501. doi:10.1017/cjn.2021.146. Epub 2021 Jun 24. PMID: 34346303. - Varhaug KN, Hikmat O, Bindoff LA.
[Mitochondrial disease caused by the m.3243A>G mutation].
Tidsskr Nor Laegeforen. 2022 Jun 27;142(10). doi:10.4045/tidsskr.21.0729. Print 2022 Jun 28. PMID: 35763848 Review. Norwegian. - Sharma S, Hsieh YC, Dietze J, Bockwoldt M, Strømland Ø, Ziegler M, Heiland I.
Early Evolutionary Selection of NAD Biosynthesis Pathway in Bacteria.
Metabolites. 2022 Jun 21;12(7):569. doi: 10.3390/metabo12070569. PMID: 35888693. - Martin-Malpartida P, Hausvik E, Underhaug J, Torner C, Martinez A, Macias MJ.
HTSDSF Explorer, A Novel Tool to Analyze High-throughput DSF Screenings.
J Mol Biol. 2022 Jun 15;434(11):167372. doi:10.1016/j.jmb.2021.167372. Epub 2021 Nov 19. PMID: 35662461. - Markússon S, Hallin EI, Bustad HJ, Raasakka A, Xu J, Muruganandam G, Loris R, Martinez A, Bramham CR, Kursula P.
High-affinity anti-Arc nanobodies provide tools for structural and functional studies.
PLoS One. 2022 Jun 7;17(6):e0269281. doi:10.1371/journal.pone.0269281. eCollection 2022. PMID: 35671319. - Lie IA et al. (incl. Vedeler CA, Bø L, Torkildsen Ø, Myhr KM).
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study.
J Neurol Neurosurg Psychiatry. 2022 Jun 1;93(8):849-57. doi:10.1136/jnnp-2021-328568. Online ahead of print. PMID: 35649699. - Borda MG, Pérez-Zepeda MU, Jaramillo-Jimenez A, Chaudhuri KR, Tovar-Rios DA, Wallace L, Batzu L, Rockwood K, Tysnes OB, Aarsland D, Alves G.
Frailty in Parkinson’s disease and its association with early dementia: A longitudinal study. Parkinsonism
Relat Disord. 2022 Jun;99:51-57. doi: 10.1016/j.parkreldis.2022.05.004. Epub 2022 May 13. PMID: 35598420. - Nygaard GO, Torgauten H, Skattebøl L, Høgestøl EA, Sowa P, Myhr KM, Torkildsen Ø, Celius EG.
Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis.
Mult Scler Relat Disord. 2022 Jun;62:103812. doi:10.1016/j.msard.2022.103812. Epub 2022 Apr 17. PMID: 35462167. - Ramirez J et al. (incl. Jog M).
Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson’s Disease Patients.
Mov Disord. 2022 Jun;37(6):1304-1309. doi: 10.1002/mds.29010. Epub 2022 Apr 11. PMID: 35403259. - Eid K, Torkildsen Ø, Aarseth J, Aalstad M, Bhan A, Celius EG, Cortese M, Daltveit AK, Holmøy T, Myhr KM, Riise T, Schüler S, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH.
Association of adverse childhood experiences with the development of
multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):645-650. doi: 10.1136/jnnp-2021-328700. Epub 2022 Apr 4. PMID: 35379699. - Chen A, Kristiansen CK, Høyland LE, Ziegler M, Wang J, Sullivan GJ, Li X, Bindoff LA, Liang KX.
POLG mutations lead to abnormal mitochondrial remodeling during neural differentiation of human pluripotent stem cells via SIRT3/AMPK pathway inhibition.
Cell Cycle. 2022 Jun;21(11):1178-1193. doi: 10.1080/15384101.2022.2044136. Epub 2022 Mar 17. PMID: 35298342. - Ozzoude M et al. (incl. Jog M).
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases.
Geroscience. 2022 Jun;44(3):1575-1598. doi: 10.1007/s11357-022-
00539-x. Epub 2022 Mar 16. PMID: 35294697. - Kvistad CE, Kråkenes T, Gjerde C, Mustafa K, Rekand T, Bø L.
Safety and Clinical Efficacy of Mesenchymal Stem Cell Treatment in Traumatic Spinal Cord Injury, Multiple Sclerosis and Ischemic Stroke - A Systematic Review and Meta-Analysis.
Front Neurol. 2022 May 30;13:891514. doi: 10.3389/fneur.2022.891514. eCollection 2022. PMID: 35711260. - Gedde MH, Husebo BS, Mannseth J, Naik M, Selbaek G, Vislapuu M, Berge LI.
The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial.
BMC Med. 2022 May 26;20(1):186. doi:10.1186/s12916-022-02382-5. PMID: 35614509. - Flønes IH, Nyland H, Sandnes DA, Alves GW, Tysnes OB, Tzoulis C.
Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex
I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease.
Biomolecules. 2022 May 25;12(6):747. doi: 10.3390/biom12060747. PMID:
35740871. - Borda MG, Jaramillo-Jimenez A, Giil LM, Tovar-Rios DA, Soennesyn H, Aarsland D.
Body mass index trajectories and associations with cognitive decline in people with Lewy body dementia and Alzheimer’s disease.
Health Sci Rep. 2022 May 2;5(3):e590. doi:10.1002/hsr2.590. eCollection 2022 May. PMID: 35509416. - Gonzalez MC, Dalen I, Maple-Grødem J, Tysnes OB, Alves G.
Parkinson’s disease clinical milestones and mortality.
NPJ Parkinsons Dis. 2022 May 12;8(1):58. doi: 10.1038/s41531-022-00320-z. PMID: 35550520. - Kulshreshtha D, Ganguly J, Jog M.
Expanding the Clinical Spectrum of RFC1 Gene Mutations.
J Mov Disord. 2022 May;15(2):167-170. doi: 10.14802/jmd.21117. Epub 2022 Mar 22. PMID: 35306791. - Szwedo AA, Dalen I, Pedersen KF, Camacho M, Bäckström D, Forsgren L, Tzoulis C, Winder-Rhodes S, Hudson G, Liu G, Scherzer CR, Lawson RA, Yarnall AJ, Williams-Gray CH, Macleod AD, Counsell CE, Tysnes OB, Alves G, Maple-Grødem J; Parkinson’s Incidence Cohorts Collaboration.
GBA and APOE Impact Cognitive Decline in Parkinson’s Disease: A 10-Year Population-Based Study.
Mov Disord. 2022 May;37(5):1016-1027. doi: 10.1002/mds.28932. Epub 2022 Feb 2. PMID: 35106798. - Sharma S, Sethi SK, Reese D, Gharabaghi S, Yerramsetty KK, Palutla VK, Chen Y, Haacke EM, Jog MS.
Brain iron deposition and movement disorders in hereditary haemochromatosis without liver failure: A cross-sectional study.
Eur J Neurol. 2022 May;29(5):1417-1426. doi: 10.1111/ene.15242. Epub 2022 Jan 14. PMID: 34989476. - Lie IA, Kerklingh E, Wesnes K, van Nederpelt DR, Brouwer I, Torkildsen Ø, Myhr KM, Barkhof F, Bø L, Vrenken H.
The effect of gadolinium-based contrastagents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Eur Radiol. 2022 May;32(5):3576-3587. doi: 10.1007/s00330-021-08405-8. Epub 2022 Jan 3. PMID: 34978580. - Skulstad Johanson GA, Tysnes OB, Bjerknes TL.
Use of Off-Label Drugs and Nutrition Supplements among Patients with Amyotrophic Lateral Sclerosis in Norway.
Neurol Res Int. 2022 Apr 12;2022:1789946. doi: 10.1155/2022/1789946.
eCollection 2022. PMID: 35464630. - Lie IA, Weeda MM, Mattiesing RM, Mol MAE, Pouwels PJW, Barkhof F, Torkildsen Ø, Bø L, Myhr KM, Vrenken H.
Relationship Between White Matter Lesions and Gray Matter Atrophy in
Multiple Sclerosis: A Systematic Review.
Neurology. 2022 Apr 12;98(15):e1562-e1573. doi: 10.1212/WNL.0000000000200006. Epub 2022 Feb 16. PMID: 35173016. - Mayala S, Haugsøen JB.
Threshold estimation based on local minima for nucleus and cytoplasm
segmentation.
BMC Med Imaging. 2022 Apr 26;22(1):77. doi: 10.1186/s12880-022-00801-w.
PMID: 35473495 - Flønes IH, Tzoulis C.
Mitochondrial Respiratory Chain Dysfunction-A Hallmark Pathology of Idiopathic Parkinson’s Disease?
Front Cell Dev Biol. 2022 Apr 1;10:874596. doi: 10.3389/fcell.2022.874596.
eCollection 2022. PMID: 35433702. - Husebo BS, Vislapuu M, Cyndecka MA, Mustafa M, Patrascu M. Understanding Pain and Agitation Through System Analysis Algorithms in People With Dementia. A Novel Explorative Approach by the DIGI.PAIN Study. Front Pain Res (Lausanne). 2022 Mar 17;3:847578. doi: 10.3389/fpain.2022.847578. eCollection 2022. PMID: 35369536.
- Rana N, Suliman S, Mohamed-Ahmed S, Gavasso S, Gjertsen BT, Mustafa K. Systemic and local innate immune responses to surgical co-transplantation of mesenchymal stromal cells and biphasic calcium phosphate for bone regeneration.
Acta Biomater. 2022 Mar 15;141:440-453. doi: 10.1016/j.actbio.2021.12.027. Epub 2021 Dec 28. PMID: 34968726. - König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO.
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination.
JAMA Neurol. 2022 Mar 1;79(3):307-309. doi: 10.1001/jamaneurol.2021.5109. PMID: 35072702. - Bjørke-Monsen AL, Bjørk MH, Storstein A, Ueland PM, Tysnes OB.
Severe Hyperhomocysteinemia in a Patient with Parkinson Disease.
Clin Chem. 2022 Mar 4;68(3):396-401. doi: 10.1093/clinchem/hvab262. PMID: 35243496. - Brakedal B, Toker L, Haugarvoll K, Tzoulis C.
A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population.
NPJ Parkinsons Dis. 2022 Mar 2;8(1):19. doi: 10.1038/s41531-022-00280-4. PMID: 35236852. - Parasyri M, Brandström P, Uusimaa J, Ostergaard E, Hikmat O, Isohanni P, Naess K, de Coo IFM, Nascimento Osorio A, Nuutinen M, Lindberg C,
Bindoff LA, Tulinius M, Darin N, Sofou K.
Renal Phenotype in Mitochondrial Diseases: A Multicenter Study.
Kidney Dis (Basel). 2022 Jan 24;8(2):148-159. doi: 10.1159/000521148. eCollection 2022 Mar. PMID: 35527992. - Brakedal B, Dölle C, Riemer F, Ma Y, Nido GS, Skeie GO, Craven AR, Schwarzlmüller T, Brekke N, Diab J, Sverkeli L, Skjeie V, Varhaug K, Tysnes OB, Peng S, Haugarvoll K, Ziegler M, Grüner R, Eidelberg D, Tzoulis C.
The NADPARK study: A randomized phase I trial of nicotinamide riboside
supplementation in Parkinson’s disease.
Cell Metab. 2022 Mar 1;34(3):396-407.e6. doi: 10.1016/j.cmet.2022.02.001. PMID: 35235774. - Sallnow L et al. (incl. Husebø BS).
Report of the Lancet Commission on the Value of Death: bringing death
back into life.
Lancet. 2022 Feb 26;399(10327):837-884. doi: 10.1016/S0140-6736(21)02314-X. Epub 2022 Feb 1. PMID: 35114146. - Jain J, Son M, Debicki DB, Jog M, Casserly CS, Burneo JG, Budhram A. Epilepsia partialis continua in relapsing-remitting multiple sclerosis: A possible distinct relapse phenotype.
Clin Neurol Neurosurg. 2022 Feb;213:107099. doi:10.1016/j.clineuro.2021.107099. Epub 2021 Dec 21. PMID: 34959105. - Kulshreshtha D, Pieterman M, Gilmore G, Jog M.
Optimizing the selection of Parkinson’s disease patients for neuromodulation using the levodopa challenge test.
J Neurol. 2022 Feb;269(2):846-852. doi: 10.1007/s00415-021-10666-8. Epub 2021 Jun 30. PMID: 34191078. - Gedde MH, Husebo BS, Vahia IV, Mannseth J, Vislapuu M, Naik M, Berge LI.
Impact of COVID-19 restrictions on behavioural and psychological symptoms in home-dwelling people with dementia: a prospective cohort study (PAN.DEM).
BMJ Open. 2022 Jan 24;12(1):e050628. doi: 10.1136/
bmjopen-2021-050628. PMID: 35074810. - Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A.
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science. abj8222. Epub 2022 Jan 13. PMID: 35025605. - Zhu L, Boissy P, Duval C, Zou G, Jog M, Montero-Odasso M, Speechley M. How Long Should GPS Recording Lengths Be to Capture the Community
Mobility of An Older Clinical Population? A Parkinson’s Example.
Sensors (Basel). 2022 Jan 12;22(2):563. doi: 10.3390/s22020563. PMID:
35062523. - Bueno-Carrasco MT, Cuéllar J, Flydal MI, Santiago C, Kråkenes TA, Kleppe R, López-Blanco JR, Marcilla M, Teigen K, Alvira S, Chacón P, Martinez A, Valpuesta JM.
Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.
Nat Commun. 2022 Jan 10;13(1):74. doi: 10.1038/s41467-021-27657-y. PMID: 35013193. - Cortese M, Bjornevik K, Chitnis T, Ascherio A, Munger KL.
Aging with multiple sclerosis: A longitudinal study of physical function, mental
health, and memory in two cohorts of US women.
Mult Scler. 2022 Jan;28(1):121-131. doi:10.1177/13524585211007739. Epub 2021 Apr 16.PMID: 33860717. - Jog M, Fasano A.
Editorial on the Special Issue “Botulinum Toxin for the Treatment of Neurological Disorders: Where We Are and Where We Need to Go”.
Toxins (Basel). 2022 Jan 5;14(1):41. doi: 10.3390/toxins14010041. PMID: 35051018. - Olsen CG et al. (incl. Tysnes OB).
Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.
Neuroepidemiology. 2022;56(4):271-282. doi:10.1159/000525091. Epub 2022 May 16. PMID: 35576897. - Ganguly J, Tuesta Bernaola M, Jog M.
Role of Vitamins in Advanced Therapy for Parkinson’s Disease: Decoding the Paradox.
Can J Neurol Sci. 2022 Jan;49(1):3-4. doi: 10.1017/cjn.2021.106.
Epub 2021 May 14. PMID: 33988104. - Haugarvoll K, Ross OA.
Book chapter Genetics of Tremors, p. 66-74 in Tremors by eds. Testa C and
Haubenberger D, Oxford Academic 2022, https://doi.org/10.1093/med/9780197529652.001.0001. - Engen, C. (2022).
The Dynamics of the Labelling Game: An Essay On FLT3 Mutated Acute Myeloid Leukaemia FLT3 Mutated Acute Myeloid Leukaemia. Precision Oncology and Cancer Biomarkers: Issues at Stake and Matters of Concern. A. Bremer and R. Strand. Cham, Springer International Publishing:
121-132. - Engen, C. (2022).
Introduction to the Imaginary of Precision Oncology. Precision Oncology and Cancer Biomarkers: Issues at Stake and Matters of Concern. A. Bremer and R. Strand. Cham, Springer International Publishing: 17-28. - Strand, R. and C. Engen (2022).
Filled with Desire, Perceive Molecules. Precision Oncology and Cancer Biomarkers: Issues at Stake and Matters of Concern. A. Bremer and R. Strand. Cham, Springer International Publishing: 251-267.